Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
- PMID: 20092374
- DOI: 10.3109/02841850903482901
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
Abstract
Background: Brain metastases and primary high-grade gliomas, including glioblastomas multiforme (GBM) and anaplastic astrocytomas (AA), may be indistinguishable by conventional magnetic resonance (MR) imaging. Identification of these tumors may have therapeutic consequences.
Purpose: To assess the value of MR spectroscopy (MRS) using short and intermediate echo time (TE) in differentiating solitary brain metastases and high-grade gliomas on the basis of differences in metabolite ratios in the intratumoral and peritumoral region.
Material and methods: We performed MR imaging and MRS in 73 patients with histologically verified intraaxial brain tumors: 53 patients with high-grade gliomas (34 GBM and 19 AA) and 20 patients with metastatic brain tumors. The metabolite ratios of Cho/Cr, Cho/NAA, and NAA/Cr at intermediate TE and the presence of lipids at short TE were assessed from spectral maps in the tumoral core, peritumoral edema, and contralateral normal-appearing white matter. The differences in the metabolite ratios between high-grade gliomas/GBM/AA and metastases were analyzed statistically. Cutoff values of Cho/Cr, Cho/NAA, and NAA/Cr ratios in the peritumoral edema, as well as Cho/Cr and NAA/Cr ratios in the tumoral core for distinguishing high-grade gliomas/GBM/AA from metastases were determined by receiver operating characteristic (ROC) curve analysis.
Results: Significant differences were noted in the peritumoral Cho/Cr, Cho/NAA, and NAA/ Cr ratios between high-grade gliomas/GBM/AA and metastases. ROC analysis demonstrated a cutoff value of 1.24 for peritumoral Cho/Cr ratio to provide sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of 100%, 88.9%, 80.0%, and 100%, respectively, for discrimination between high-grade gliomas and metastases. By using a cutoff value of 1.11 for peritumoral Cho/NAA ratio, the sensitivity was 100%, the specificity was 91.1%, the PPV was 83.3%, and the NPV was 100%.
Conclusion: The results of this study demonstrate that MRS can differentiate high-grade gliomas from metastases, especially with peritumoral measurements, supporting the hypothesis that MRS can detect infiltration of tumor cells in the peritumoral edema.
Comment in
-
Response to article "Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors".Acta Radiol. 2010 Apr;51(3):326-8. doi: 10.3109/02841850903504159. Acta Radiol. 2010. PMID: 20192894 No abstract available.
Similar articles
-
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13. Eur J Radiol. 2011. PMID: 20708868
-
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.Acta Radiol. 2009 Jul;50(6):682-9. doi: 10.1080/02841850902933123. Acta Radiol. 2009. PMID: 19449234
-
3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.Int J Neurosci. 2013 Aug;123(8):537-43. doi: 10.3109/00207454.2013.774395. Epub 2013 Mar 11. Int J Neurosci. 2013. PMID: 23390934 Review.
-
[Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(8):1342-4. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18753055 Chinese.
-
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.Eur Radiol. 2016 Aug;26(8):2670-84. doi: 10.1007/s00330-015-4046-z. Epub 2015 Oct 15. Eur Radiol. 2016. PMID: 26471274
Cited by
-
Advanced magnetic resonance imaging biomarkers of cerebral metastases.Cancer Imaging. 2012 Aug 10;12(1):245-52. doi: 10.1102/1470-7330.2012.0012. Cancer Imaging. 2012. PMID: 22935843 Free PMC article. Review.
-
Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map.J Neurooncol. 2014 Oct;120(1):187-98. doi: 10.1007/s11060-014-1544-9. Epub 2014 Jul 31. J Neurooncol. 2014. PMID: 25079117
-
Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report.J Clin Med Res. 2017 Jan;9(1):74-78. doi: 10.14740/jocmr2775w. Epub 2016 Nov 24. J Clin Med Res. 2017. PMID: 27924180 Free PMC article.
-
Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.Cancer Imaging. 2012 Oct 26;12(3):423-36. doi: 10.1102/1470-7330.2012.0038. Cancer Imaging. 2012. PMID: 23108208 Free PMC article.
-
Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature.J Radiol Case Rep. 2012 Oct;6(10):1-10. doi: 10.3941/jrcr.v6i10.1134. Epub 2012 Oct 1. J Radiol Case Rep. 2012. PMID: 23378871 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical